JP Morgan Private Wealth Advisors’s Moderna MRNA Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.57M	Buy	+15,246	New	+$1.7M	﹤0.01%	822
2023 Q2	–	Sell	-46,341	Closed	-$7.12M	–	1745
2023 Q1	$7.12M	Buy	46,341 +2,870	+7%	+$473K	0.02%	505
2022 Q4	$7.81M	Buy	43,471 +4,089	+10%	+$669K	0.02%	477
2022 Q3	$4.66M	Buy	39,382 +18,636	+90%	+$2.83M	0.01%	575
2022 Q2	$2.96M	Sell	20,746 -39,006	-65%	-$5.58M	0.01%	718
2022 Q1	$10.3M	Sell	59,752 -36,096	-38%	-$6.08M	0.02%	436
2021 Q4	$24.3M	Sell	95,848 -3,019	-3%	-$883K	0.05%	285
2021 Q3	$38M	Buy	98,867 +9,679	+11%	+$3.57M	0.09%	215
2021 Q2	$21M	Buy	89,188 +74,558	+510%	+$13.3M	0.05%	298
2021 Q1	$1.92M	Sell	14,630 -792	-5%	-$115K	0.01%	787
2020 Q4	$1.61M	Buy	15,422 +4,799	+45%	+$486K	0.01%	827
2020 Q3	$752K	Sell	10,623 -334	-3%	-$23.3K	﹤0.01%	1002
2020 Q2	$704K	Buy	10,957 +351	+3%	+$19.2K	﹤0.01%	939
2020 Q1	$318K	Buy	+10,606	New	+$244K	﹤0.01%	1108

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

JP Morgan Private Wealth Advisors's MRNA Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors opened a new position in Moderna (MRNA) in Q3 2023: 15,246 shares worth $1.57M. The stake represents ﹤0.01% of the portfolio and ranks #822 among its holdings. This is a return to the name: JP Morgan Private Wealth Advisors previously reported a position in MRNA as recently as Q1 2023.

JP Morgan Private Wealth Advisors first reported a position in MRNA in Q1 2020 and has held it in 14 quarters since. The position peaked at $38M in Q3 2021. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

JP Morgan Private Wealth Advisors held 15,246 shares of Moderna worth $1.57M as of Q3 2023.
Moderna was a new JP Morgan Private Wealth Advisors position in Q3 2023.
Moderna made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #822 holding.
JP Morgan Private Wealth Advisors first reported a position in Moderna in Q1 2020 and has held it in 14 quarters since.
JP Morgan Private Wealth Advisors's Moderna position peaked at $38M in Q3 2021.
890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.